Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy

BACKGROUND: Developing the ability to use tumor-directed therapies to trigger potentially therapeutic immune responses against cancer antigens remains a high priority for cancer immunotherapy. We hypothesized that histotripsy, a novel non-invasive, non-thermal ablation modality that uses ultrasound-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Immunother Cancer
Auteurs principaux: Qu, Shibin, Worlikar, Tejaswi, Felsted, Amy E, Ganguly, Anutosh, Beems, Megan V, Hubbard, Ryan, Pepple, Ashley L, Kevelin, Alicia A, Garavaglia, Hannah, Dib, Joe, Toma, Mariam, Huang, Hai, Tsung, Allan, Xu, Zhen, Cho, Clifford Suhyun
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2020
Sujets:
Clinical/Translational Cancer Immunotherapy
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057529/
https://ncbi.nlm.nih.gov/pubmed/31940590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000200
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires